Form 4: Centene CEO Sarah London Forfeits Stock Units Following Performance Assessment

Centene CEO Sarah London forfeited 58,695 performance stock units after the company determined that certain financial performance objectives were not met.

Summary

• On February 4, 2025, Centene CEO Sarah London forfeited 58,695 performance stock units due to the company's performance over the applicable period.
• These units were originally granted on December 15, 2021, and March 29, 2022, and were subject to vesting based on specific financial performance objectives.
• Additionally, 20,825 shares were withheld for taxes upon the vesting of previously reported performance stock units at a price of $64.82.
• Following these transactions, London directly owns 585,551 shares of Centene common stock, which includes 377,818 shares of previously granted restricted stock units and performance stock units subject to vesting requirements.
• London also holds options to purchase 13,449 shares of common stock at an exercise price of $81.85, which may become exercisable on or after December 15, 2024, if Centene's stock price reaches $100 for 20 consecutive trading days.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the forfeiture of stock units, indicating that the company's performance did not meet certain targets. However, the document is primarily factual and does not contain overtly negative language.

Negatives

• The forfeiture of 58,695 performance stock units indicates that Centene did not achieve certain financial performance objectives during the relevant period.

Risks

• The forfeiture of stock units could negatively impact investor sentiment, as it suggests that the company's performance did not meet expectations.
• The potential failure to meet the $100 stock price target for the performance stock options could result in the options not becoming exercisable, impacting potential future compensation for the CEO.

Future Outlook

The document does not contain specific forward-looking statements about Centene's future performance, but it does indicate that future vesting of restricted stock units and performance stock units is contingent on meeting certain requirements.

Industry Context

Executive compensation and stock ownership are common topics in the healthcare industry, particularly for large companies like Centene. Forfeiture of stock units due to unmet performance targets is not uncommon and reflects the performance-based nature of executive compensation packages.

Comparison to Industry Standards

• Centene's executive compensation structure, including performance-based stock units and options, is similar to that of other large healthcare companies such as UnitedHealth Group (UNH) and Anthem (now Elevance Health).
• These companies also use a mix of salary, stock options, and performance-based bonuses to incentivize their executives.
• The specific performance metrics used for vesting may vary, but the overall approach is consistent with industry standards for aligning executive compensation with shareholder value.

Stakeholder Impact

• Shareholders may view the forfeiture of stock units negatively, as it suggests that the company's performance did not meet expectations.
• Employees may be affected if the company's overall performance impacts their compensation or job security.

Key Dates

Keywords

Centene, Sarah London, stock forfeiture, performance stock units, Form 4, beneficial ownership, executive compensation